Cite
MLA Citation
G Mocci et al.. “P583 Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study.” Journal of Crohn's and colitis, vol. 15, n.d., pp. S536–S537. http://access.bl.uk/ark:/81055/vdc_100130765717.0x000013